###### Strengths and limitations of this study

-   We have carried out a comprehensive and robust systematic review in accordance with the PRISMA guidelines.

-   We included a range of patient-related predictors and did not limit ourselves to the most common predictors. This led to a broad overview of predictors evaluated.

-   We screened a large number of literature sources, and all reviewing and data extraction was carried out by one author (LDB) and double checked by a second author (LWAHVB).

-   Owing to the heterogeneity across studies regarding measurement tool, predictor and duration of follow-up we could not apply a meta-analysis.

-   The predictors like quadriceps strength, education, socioeconomic status and alcohol consumption were reported only a few times and therefore conclusions cannot be reached.

Introduction {#s1}
============

Total hip arthroplasty (THA) is a surgical procedure performed to reduce pain and improve function in patients with osteoarthritis (OA) of the hip. According to the Agency for Healthcare Research and Quality, more than 305 000 total hip replacements are performed each year in the USA.[@R1] Following THA, the majority of patients experience reductions in pain, improvements in function and better health-related quality of life.[@R2] However, not all patients achieve the same level of functional improvement after THA. Specifically, more than 30% of patients undergoing THA report moderate-to-severe activity limitations 2 years post-THA.[@R3] It is unclear which factors are associated with these limitations in function.[@R4] [@R5]

In the previous decade, many studies have been published investigating the predictors of functional outcome after THA. Young *et al* published a systematic review on this topic in 1998. Since then considerable research has been published on predictors of functional outcome which justifies a new systematic review.[@R6] Therefore, we conducted a systematic review of predictors of mid-term and long-term functional outcome after THA.

Methods {#s2}
=======

Registration {#s2a}
------------

This systematic review is registered at Prospero (<http://www.crd.york.ac.uk/PROSPERO/>) with registry number CRD42015016929.

Selection criteria {#s2b}
------------------

Studies that met the following criteria were included in our review: (1) included patients undergoing a THA; (2) included physical functioning was an outcome measure; (3) had at least one variable that was considered as a predictor of physical functioning and (4) was written in English. We did not select a time period.

Search strategy {#s2c}
---------------

With the guidance of an independent medical librarian, we conducted a literature search through four medical databases: Web of Science; CINAHL; EMBASE and PubMed. This literature search was performed on 23 June 2015. In Web of Science we used the following search terms: TOPIC: (total hip arthroplasty) AND TOPIC: (predictor\*). In CINAHL we searched for: (MM "Arthroplasty, Replacement, Hip") AND predictor\*. In EMBASE we searched for: exp hip arthroplasty/exp prediction/or exp predictor variable/exp prognosis/or exp functional assessment/or exp treatment outcome/or exp daily life activity/. In PubMed we searched for ("Arthroplasty, Replacement, Hip"(Majr) OR "Hip Prosthesis"(Majr)) AND (predictor\* OR risk Factor\* OR risk assessment OR predictive value of tests OR prognostic factor\* OR Prognostic\*) AND (HOOS OR "hip disability and osteoarthritis outcome score" OR WOMAC OR "Western Ontario and McMaster Universities Arthritis Index" OR "Harris hip score" OR HHS OR SF-12 OR short form 12 OR SF 36 OR "short form 36" OR Trendelenburg OR TUG OR "timed up and go" OR "Oxford hip score" OR "IOWA hip score" OR "Functional recovery score" OR FRS OR AFI OR "Hospital for special surgery" OR AAOS OR "Charnley hip score" OR HSS OR LEGS OR "Mayo clinical hip score"). The results of these four different searches were combined in Reference Manager and duplicates were discarded.

Study selection {#s2d}
---------------

Two of the authors (LWAHVB and TP) independently screened the titles and abstracts of all the articles using the aforementioned selection criteria. Both reviewers screened the full-text articles of the articles found eligible in the first round. A third author (LDB) compared these results and in case of different opinions, a consensus was reached. The study selection procedure is schematically presented in [figure 1](#BMJOPEN2015010725F1){ref-type="fig"}.

![Flow chart of the study selection procedure.](bmjopen2015010725f01){#BMJOPEN2015010725F1}

Data extraction {#s2e}
---------------

One of the authors (LDB) extracted the data, which was double checked by a second author (LWAHVB). From each article, the following information was extracted: (1) predictor variable; (2) author; (3) year of publication; (4) level of evidence; (5) number of patients; (6) measurement tools used; (7) follow-up period; (8) significance level; (9) association between predictor variable and outcome measure; and (10) predictor level of measurement ([table 1](#BMJOPEN2015010725TB1){ref-type="table"}). The results were categorised by predictor variable.

###### 

Methodological quality of included studies

  Study                             Study design          Risk of bias   Inconsistency   Indirectness   Imprecision   Other considerations      Grade
  --------------------------------- --------------------- -------------- --------------- -------------- ------------- ------------------------- ----------
  Kessler and Käfer[@R24]           Observational study   Not serious    Not serious     Not serious    Not serious   Strong association        Moderate
  Aranda Villalobos *et al*[@R31]   Observational study   Not serious    Not serious     Not serious    Not serious   None                      Low
  Nankaku *et al*[@R26]             Observational study   Not serious    Not serious     Not serious    Not serious   Strong association        Moderate
  Slaven[@R28]                      Observational study   Not serious    Not serious     Not serious    Not serious   None                      Low
  Moran *et al*[@R25]               Observational study   NA             Not serious     Not serious    Not serious   Strong association        Moderate
  Stevens *et al*[@R30]             Observational study   Not serious    Not serious     Not serious    Not serious   Strong association        Moderate
  Wang *et al*[@R32]                Observational study   Not serious    Not serious     Not serious    Not serious   None                      Moderate
  Dowsey *et al*[@R20]              Observational study   Serious        Not serious     Not serious    Not serious   Strong association        Low
  Judge *et al*[@R33]               Observational study   Not serious    Not serious     Not serious    Not serious   Very strong association   High
  Bergschmidt *et al*[@R17]         Observational study   Not serious    Not serious     Not serious    Not serious   Strong association        Moderate
  Jones *et al*[@R22]               Observational study   Not serious    Not serious     Not serious    Not serious   Strong association        Moderate
  Smith *et al*[@R29]               Observational study   Not serious    Not serious     Serious        Not serious   Strong association        Moderate
  Judge *et al*[@R23]               Observational study   Not serious    Not serious     Not serious    Not serious   Very strong association   High
  Bischoff *et al*[@R18]            Observational study   Not serious    Not serious     Not serious    Not serious   Strong association        Moderate
  Gandhi *et al*[@R21]              Observational study   Serious        Not serious     Not serious    Not serious   None                      Low
  Nilsdotter *et al*[@R27]          Observational study   Not serious    Serious         Not serious    Not serious   Strong association        Low
  Davis *et al*[@R19]               Observational study   Not serious    Not serious     Not serious    Not serious   Very strong association   High
  Hamilton *et al*[@R35]            Observational study   Not serious    Not serious     Not serious    Not serious   None                      Low
  Quintana *et al*[@R37]            Observational study   Not serious    Not serious     Not serious    Not serious   Strong association        Moderate
  Nilsdotter and Lohmander[@R36]    Observational study   Not serious    Not serious     Not serious    Not serious   Strong association        Moderate
  Dowsey *et al*[@R34]              Observational study   Not serious    Not serious     Not serious    Not serious   Very strong association   High
  Lavernia, 2011[@R38]              Observational study   Serious        Not serious     Not serious    Not serious   Strong association        Low
  Mahomed *et al*[@R39]             Observational study   Not serious    Not serious     Not serious    Not serious   Strong association        Moderate
  Vogl *et al*[@R43]                Observational study   Not serious    Serious         Not serious    Not serious   NA                        Low
  Clement *et al*[@R42]             Observational study   Not serious    Not serious     Not serious    Not serious   Very strong association   High
  Johansson *et al*[@R40]           Observational study   Not serious    Not serious     Not serious    Not serious   Strong association        Moderate
  Fortin *et al*[@R41]              Observational study   Not serious    Not serious     Not serious    Serious       Strong association        Low
  Badura-Brzoza *et al*[@R44]       Observational study   Not serious    Not serious     Not serious    Not serious   Strong association        Moderate
  Holstege *et al*[@R46]            Observational study   Not serious    Not serious     Not serious    Not serious   Strong association        Moderate
  Schafer *et al*[@R47]             Observational study   Not serious    Not serious     Not serious    NA            Strong association        Low
  Graves *et al*[@R48]              Observational study   Not serious    Not serious     Not serious    Not serious   Strong association        Moderate
  Lavernia, 2014[@R49]              Observational study   Not serious    Not serious     Not serious    NA            None                      Low
  Lavernia *et al*[@R45]            Observational study   Not serious    Not serious     Not serious    Not serious   Strong association        Moderate

High: true effect lies close to the estimate of the effect.

Moderate: true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.

Low: true effect may be substantially different from the estimate of effect.

Very low: true effect is likely to be substantially different from the estimate of effect.

GRADE, Grading Recommendations Assessment Development and Evaluation; NA, not applicable.

Methodological quality assessment {#s2f}
---------------------------------

The level of evidence of all studies was determined by one of the authors (LDB) using the GRADE rating scheme (<http://www.gradeworkinggroup.org>).

Measurement tools {#s2g}
-----------------

We aimed to include all predictors mentioned in previous studies, and did not limit ourselves to the most common predictors. Some of the widely used measurement tools to define functional outcome are the Harris Hip Score (HHS),[@R7] Oxford Hip Score (OHS),[@R8] [@R9] Short Form-36 (SF-36),[@R10] Lower Extremity Functional Scale (LEFS),[@R11] Timed Up and Go (TUG) test[@R12] [@R13] and the Western Ontario and McMaster Universities OA Index (WOMAC).[@R14] We used all these measurement tools as outcome in this study.

Best evidence synthesis {#s2h}
-----------------------

A follow-up period up to 24 months was considered as 'short term' and a follow-up period of more than 24 months was considered as 'long term'. Results were divided into four categories of evidence: strong evidence: at least 60% of the studies, with a minimum of three studies, describing the same significant (p\<0.05) association. Weak evidence: (1) only two studies describe the same significant association; (2) three studies describe the same association out of which two are significant and one is not significant (p\>0.05). Limited evidence: (1) only one study available; (2) more studies were available of which none found a significant association. Inconsistent evidence: all other scenarios.[@R15] No conclusions can be drawn in this literature review when no or inconsistent evidence is available.

This systematic review conforms to the PRISMA statement.[@R16]

Results {#s3}
=======

Selection and methodological quality {#s3a}
------------------------------------

The initial search resulted in 1092 citations ([figure 1](#BMJOPEN2015010725F1){ref-type="fig"}) and 33 articles met our eligibility criteria. The articles included were designated as level of evidence low (11), moderate (17) or high (5; [table 1](#BMJOPEN2015010725TB1){ref-type="table"})

Measures of functional outcome {#s3b}
------------------------------

Multiple outcome measures were used across these studies including the HHS, OHS, SF-36 physical function (PF), LEFS, TUG and the WOMAC score. The follow-up period ranged from 3 to 72 months with an average of 18 (SD 17) months ([table 2](#BMJOPEN2015010725TB2){ref-type="table"}).

###### 

Characteristics of all included studies

  Author, year, nr          Age baseline    N of pts   Female (n, %)   Inclusion criteria           Follow-up time     Measurement tool
  ------------------------- --------------- ---------- --------------- ---------------------------- ------------------ -------------------
  Badura-Brzoza, 2009, 42   61 (54--75)     156        59 (58%)        Primary THA, OA              6 months           SF-36 PF
  Bergschmidt, 2010, 113    66 (58--74)     100        48 (50%)        Primary THA, OA              6--12--24 months   HHS
                                                                                                                       WOMAC
                                                                                                                       SF-12
  Bischoff, 2004, 51        73.1 (65--93)   922        60%             OA, primary THA \>65 years   3 years            WOMAC PF
  Clement, 2011, 101        68.1 (65--74)   1312       NA              Primary OA, THR              12 months          OHS
                                                                                                                       SF-12
  Davis, 2011, 100          69 (34--96)     1617       994             Cemented THA                 5 years            HHS
                                                                                                                       SF-36 PF
  Dowsey, 2010, 32          68.6/67/65.6    471        60.70%          Primary THA OA               12 months          HHS
                                                                                                                       SF-12 PF
  Dowsey, 2014, 15          68.4            835        60.10%          Primary THA                  12 months          SF-12
  Fortin, 2002, 145         65.7            222        59%             Primary THA OA               2 years            WOMAC
                                                                                                                       SF-36
  Hamilton, 2012, 17        68.1            1410       57.20%          Primary THA OA               6--12 months       OHS
                                                                                                                       SF-12
  Gandhi, 2010, 30          63.2 (13.7)     636        53.50%          \<18 years, primary OA       3.3 years          WOMAC
                                                                                                                       SF-36 PF
  Graves, 2014, 29          59.5            459        61.00%          THA OA                       10\. 4 months      WOMAC
                                                                                                                       SF-36
  Holstege, 2011, 102       72.7 (6.8)      55         41 (74,5)       THA OA                       3 months           WOMAC PF
  Johansson, 2010, 114      67 (7)          75         36 (48%)        THA OA                       6--12--24 months   HHS
                                                                                                                       WOMAC
                                                                                                                       SF-36
  Jones, 2012, 90           68.2 (10.9)     231        138 (60%)       Primary THA                  6--36 months       WOMAC
  Judge, 2013, 14           70              1431       887 (62%)       OA                           1--6 years         OHS
  Kessler, 2007, nr 131     63.6            76         44.8 (59%)      THA OA                       3 months           WOMAC
  Lavernia, 2014, 73        70              60         48 (80%)        Primary THA                  3--24 months       QWB-7
                                                                                                                       SF-36 PF
                                                                                                                       WOMAC
                                                                                                                       HHS
  Lavernia, 2013, 81        62              191        70              Primary THA                  12 months          WOMAC
                                                                                                                       SF-36
  Lavernia, 2011, 103       61 (15)         532        59%             THA                          6--7 years         SF-26
                                                                                                                       HHS
                                                                                                                       WOMAC
  Mahomed, 2002, 149        66 (9)          103        57 (55%)        THA OA                       6 months           WOMAC PF
                                                                                                                       SF-36 PCS
  Moran, 2005, 136          68              749        61%             Primary THA                  6, 18 months       HHS
  Nankaku, 2013, 83         60.4            204        173             THA OA                       6 months           Ambulatory status
  Nilsdotter, 2002, 147     71              148        83              THA OA                       3--6--12 months    WOMAC
                                                                                                                       SF-36
  Nilsdotter, 2003, 52      71              211        106             Primary THA                  3, 6 years         WOMAC PF
  Quintana, 2009, 35        69.1            788        381 (48%)       Primary THA OA               6--24 months       SF-36 PF
                                                                                                                       WOMAC
  Schafer, 2010, 110        61              1007       55%             Primary THA                  6 months           WOMAC
  Slaven, 2012, 15          68.2 (8.2)      40         22 (55%)        Primary THA                  6 months           LEFS
  Smith, 2012, 92           68.5 (9.9)      1683       NA              Primary THA                  3 years            HHS
  Stevens, 2012, 22         70.3 (8.2)      653        74.20%          Primary THA, OA              52\. 4 weeks       WOMAC
  Villalobos, 2012, 80      62.39 (13.6)    63         35 (55.55%)     Primary THA                  3 months           HHS
                                                                                                                       OHS
                                                                                                                       WOMAC
                                                                                                                       SF-12 PF
  Vogle, 2014, 108          68              321        58%             Primary THA                  6 months           WOMAC
  Wang, 2010, 107           61.65           97         62.40%          OA/osteonecrosis             3--12--24 months   WOMAC

HHS, Harris Hip Score; LEFS, Lower Extremity Functional Scale; N of pts, number of patients; NA, not applicable; OHS, Oxford Hip Score; PCS, physical component summary scale; PF, physical function; QWB; quality of well-being index; SF-36 PF, Short Form 36 physical function; THA, total hip arthroplasty; THR, total hip replacement; WOMAC, Western Ontario and Mcmaster Universities Osteoarthritis Index.

Predictive factors of functional outcome {#s3c}
----------------------------------------

### Body mass index {#s3c1}

Eighteen studies evaluated body mass index (BMI) as a potential predictor of functional outcome after THA[@R17] ([table 3](#BMJOPEN2015010725TB3){ref-type="table"}). A total of 14 432 patients were included in all articles concerning the impact of BMI, with a mean follow-up time of 22 months. The applied levels of measurement of BMI were continuous, dichotomous or categorical.

###### 

Studies reporting BMI as possible predictor of functional outcome after THA

                                        Measurement                 FU period   Significance                
  ------------------- ---------- ------ --------------------------- ----------- -------------- ------------ ----------------------------------------------
  Kessler, 2007       Moderate   76     WOMAC                       ST (3 m)    0.49           No           Cont (BMI)
  Villalobos, 2012    Low        63     SF-12 PCS                   ST (3 m)    **0.004**\*    Pos          Dich
                                        WOMAC                                   **0.041**\*    Pos          (1: BMI\>28 2: BMI ?28)
                                        HHS                                     0.793\*        No           
                                        OHS                                     0.428\*        No           
  Nankaku, 2013       Moderate   204    Ambulatory status ST (6m)   0.06        No             Cont (BMI)   
  Slaven, 2012        Low        40     LEFS                        ST (6 m)    **NA**         Neg          Dich
                                                                                                            (1: BMI\>34 2: BMI ?34)
  Moran, 2005         Moderate   749    HHS                         ST (6 m)    **0.02**       Neg          Cont (BMI)
                                                                    ST (18 m)   **0.001**      Neg          
  Stevens, 2012       Moderate   653    WOMAC                       ST (12 m)   **0.001**      Neg          Cont (BMI)
  Wang, 2010          Moderate   97     WOMAC                       ST (12 m)   0.11           No           Cont (BMI)
  Dowsey, 2010        Low        471    HHS                         ST (12 m)   **\<0.01**     Neg          Cat (3)
                                        SF-12 PCS                               **0.05**       Neg          (1: BMI\<30 2: BMI 30--39 3: BMI≥40)
  Dowsey, 2014        High       835    HHS                         ST (12 m)   **\<0.0001**   Neg          Cont (BMI)
  Judge, 2014         High       4413   OHS                         ST (12 m)   **0.003**      Neg          Cat (5)
                                                                                                            (1: BMI 18.5--25 2: BMI 25--30 3: BMI 30--35
                                                                                                            4: BMI 35--40 5: BMI\>40)
  Bergschmidt, 2010   Moderate   100    HHS                         ST (24 m)   **0.007**      Neg          Cat (3)
                                                                                                            (1: BMI\<26 2: BMI 26--29 3: BMI\>29)
  Jones, 2012         Moderate   231    WOMAC                       ST (6 m)    **0.001**      Neg          Dich
                                                                    LT (36 m)   No             No           (1: BMI\>35 2: BMI ?35)
  Smith, 2012         Moderate   1683   HHS                         LT (36 m)   **\<0.01**     Neg          Cont (BMI)
  Judge, 2013         High       1431   OHS                         LT (36 m)   **\<0.001**    Neg          Cont (BMI)
  Bischoff, 2004      Moderate   922    WOMAC PF                    LT (36 m)   **NA**         Neg          Cont (BMI)
  Gandhi, 2010        Low        636    WOMAC                       LT (39 m)   0.06           No           Cont (BMI)
  Nilsdotter, 2003    Low        211    WOMAC PF                    LT (42 m)   **0.03**       Neg          Cont (BMI)
  Davis, 2011         High       1617   HHS                         LT (60 m)   **\<0.001**    Neg          Cont (BMI)

All significant results are bold; studies that used change in function as outcome are marked with \*.

BMI, body mass index; Cat, categorical; Cont, continuous; Dich, dichotomous; FU, follow-up; HHS, Harris Hip Score; LEFS, Lower Extremity Functional Scale; LT, long-term; N of pts, number of patients; NA, not applicable; Neg, negative; OHS, Oxford Hip Score; Pos, positive; SF-36 PF, Short Form 36 physical function; ST, short-term; THA, total hip arthroplasty; WOMAC, Western Ontario and Mcmaster Universities Osteoarthritis Index.

The measurement tools used to determine the functional outcome were the WOMAC score, HHS, OHS, LEFS, SF-12 PF and the ambulatory status. The classification of a high BMI ranged from \>28 to \>35 kg/m^2^.

Of the 18 studies, 13 found a significant association.[@R17] [@R22] [@R23] [@R25] [@R27] [@R33] [@R34] Twelve studies evaluated the short-term functional outcome of which eight studies[@R17] [@R20] [@R22] [@R25] [@R28] [@R30] [@R33] [@R34] found a significant negative association and one article had a significant positive association.[@R31] Of the seven studies evaluating the long-term functional outcome, five articles found a significant negative association.[@R18] [@R19] [@R23] [@R27] [@R29] Studies were designated as level of evidence low (5), moderate (9) or high (4).

Since more than 60% of the studies report a significant negative association, there is strong evidence of a negative association between BMI and short-term and long-term functional outcomes after THA. These results were consistent when we only considered the studies with high or moderate levels of evidence according to GRADE.

### Age {#s3c2}

Fifteen studies evaluated age as a possible predictor of functional outcome after THA[@R17] [@R18] [@R21] [@R23] [@R24] [@R26] [@R32] [@R34] ([table 4](#BMJOPEN2015010725TB4){ref-type="table"}). A total of 9234 patients were included in all studies that identified age as a possible predictor, with a mean follow-up time of 19 months. The applied levels of measurement of age were continuous, dichotomous or categorical.

###### 

Studies reporting age as possible predictor of functional outcome after THA

                      Measurement   FU period   Significance                                                   
  ------------------- ------------- ----------- ---------------------------- ----------- -------------- ------ ----------------------------------------
  Kessler, 2007       Moderate      76          WOMAC                        ST (3 m)    **0.03**       Neg    Cont (age)
  Nankaku, 2013       Moderate      204         Ambulatory status ST (6 m)   Yes         Neg            Dich   
                                                                                                               (1: age \>67.5 2: age ?67.5 )
  Slaven, 2012        Low           40          LEFS                         ST (6 m)    No             No     Dich
                                                                                                               (1: age \>68.5 2: age ?68.5)
  Hamilton, 2012      Low           1410        OHS                          ST (6 m)    X              No     Cont (age)
                                                SF-12                        ST (12 m)   X              No     
  Quintana, 2009      Moderate      788         WOMAC PF                     ST (6 m)    0.41           No     Dich
                                                                             ST (24 m)   **0.001**      Neg    (1: age \>70 2: age ?70)
  Stevens, 2012       Moderate      653         WOMAC                        ST (12 m)   **0.01**       Neg    Cont (age)
  Wang, 2010          Moderate      97          WOMAC                        ST (12 m)   No             No     Cont (age)
  Dowsey, 2014        High          835         HHS                          ST (12 m)   **\<0.0001**   Neg    Cont (age)
                                                SF-12 PCS                                **0.003**      Neg    
  Nilsdotter, 2002    Moderate      148         WOMAC PF                     ST (12 m)   **0.004**      Neg    Dich
                                                SF-36                                    **0.002**      Neg    (1: age \>72 2: age ?72)
  Bergschmidt, 2010   Moderate      100         HHS                          ST (12 m)   \>0.097        No     Cat (3)
                                                WOMAC                                    \>0.097        No     (1: age \<60 2: age 60--69 3: age \>69
                                                SF-12                                    \>0.097        No     
  Bischoff, 2004      Moderate      922         WOMAC PF                     LT (36 m)   X              No     Dich
                                                                                                               (1: age \>75 2: age ?75)
  Judge, 2013         High          1431        OHS                          LT (36 m)   **NA**         Neg    Cat (3)
                                                                                                               (1: age \<50 2: age 50--60 3: age \>60
  Smith, 2012         Moderate      1683        HHS                          LT (36 m)   **\<0.001**    Neg    Cont (age)
  Nilsdotter, 2003    Low           211         WOMAC PF                     LT (43 m)   **0.002**      Neg    Cont (age)
  Gandhi, 2010        Low           636         WOMAC                        LT (39 m)   **\<0.05**     Neg    Cont (age)
                                                SF-36                                    **\<0.05**            

All significant results are bold.

BMI, body mass index; Cat, categorical; Cont, continuous; Dich, dichotomous; FU, follow-up; HHS, Harris Hip Score; LEFS, Lower Extremity Functional Scale; LT, long-term; N of pts, number of patients; NA, not applicable; Neg, negative; OHS, Oxford Hip Score; Pos, positive; SF-36 PF, Short Form 36 physical function; ST, short-term; THA, total hip arthroplasty; WOMAC, Western Ontario and Mcmaster Universities Osteoarthritis Index.

The measurements tools used to determine the functional outcome were the WOMAC score, HHS, OHS, SF-36 PF, SF-12 PF and the ambulatory status. Different classifications of greater age were used, ranging from \>60 to \>75 years.

Of the 15 studies, 10 found a significant association.[@R21] [@R23] [@R24] [@R26] [@R27] [@R29] [@R30] [@R34] [@R36] [@R37] Ten studies evaluated the short-term functional outcome of which six studies found a significant negative association.[@R24] [@R26] [@R30] [@R34] [@R36] [@R37] The other four studies did not find a significant association. Of the six studies evaluating the long-term functional outcome, five studies found a significant negative association.[@R21] [@R23] [@R29] [@R36] [@R37] Studies were designated as level of evidence low (4), moderate (9) or high (2).

Since more than 60% of the studies report a significant negative association, there is strong evidence of a negative association between high age and short-term and long-term functional outcomes after THA. These results were consistent when we only considered the studies with high or moderate levels of evidence according to GRADE.

### Gender {#s3c3}

Fifteen studies evaluated gender as a possible predictor of functional outcome after THA[@R17] [@R18] [@R21] [@R22] [@R24] [@R26] [@R32] [@R34] [@R36] ([table 5](#BMJOPEN2015010725TB5){ref-type="table"}). A total of 7156 patients were included in all studies that evaluated gender as a possible predictor, with a mean follow-up time of 23.3 months. The measurement tools used to determine the functional outcome included the WOMAC score, HHS, LEFS, SF-36 and the ambulatory status.

###### 

Studies reporting gender as possible predictor of functional outcome after THA

                                        Measurement                  FU period     Significance                 
  ------------------- ---------- ------ ---------------------------- ------------- --------------- ------------ -------------------
  Kessler, 2007       Moderate   76     WOMAC                        ST (3 m)      NA              No           Dich
                                                                                                                (1: men 2: woman)
  Nilsdotter, 2002    Moderate   148    WOMAC                        ST (3 m)      0.7             No           Dich
                                        SF-36                        ST (12 m)                                  (1: men 2: woman)
  Nankaku, 2013       Moderate   204    Ambulatory status ST (6 m)   0.10          No              Dich         
                                                                                                                (1: men 2: woman)
  Slaven, 2012        Low        40     LEFS                         ST (6 m)      **0.039**       Pos, woman   Dich
                                                                                                                (1: men 2: woman)
  Quintana, 2009      Moderate   788    SF-36 PF                     ST (6 m)      **NA**          Pos, men     Dich
                                                                     ST (24 m)     NA              No           (1: men 2: woman)
  Bergschmidt, 2010   Moderate   100    HHS                          ST (12 m)     NA              No           Dich
                                                                                                                (1: men 2: woman)
  Stevens, 2012       Low        653    WOMAC                        ST (12 m)     **0.002**       Pos, men     Dich
                                                                                                                (1: men 2: woman)
  Dowsey, 2014        High       835    HHS                          ST (12 m)     0.06            No           Dich
                                                                                                                (1: men 2: woman)
  Wang, 2010          Moderate   97     WOMAC                        ST (16.8 m)   **0.0001**      Pos, men     Dich
                                                                                                                (1: men 2: woman)
  Bischoff, 2004      Moderate   922    WOMAC PF                     LT (36 m)     No              No           Dich
                                                                                                                (1: men 2: woman)
  Jones, 2012         Moderate   231    WOMAC                        LT (36 m)     0.118           No           Dich
                                                                                                                (1: men 2: woman)
  Smith, 2012         Moderate   1683   HHS                          LT (36 m)     **\<0.001**     Pos, men     Dich
                                                                                                                (1: men 2: woman)
  Gandhi, 2010        Low        636    WOMAC                        LT (39 m)     No              No           Dich
                                        SF-36 PF                                   **\<0.05**      Pos, woman   (1: men 2: woman)
  Lavernia, 2011      Low        532    WOMAC PF                     LT (42 m)     **\<0.001**\*   Pos, woman   Dich
                                                                                                                (1: men 2: woman)
  Nilsdotter, 2003    Low        211    WOMAC PF                     LT (66 m)     0.37            No           Dich
                                                                                                                (1: men 2: woman)

All significant results are bold; studies that used change in function as outcome are marked with \*.

BMI, body mass index; Dich, dichotomous; FU, follow-up; HHS, Harris Hip Score; LEFS, Lower Extremity Functional Scale; LT, long-term; N of pts, number of patients; NA, not applicable; Neg, negative; OHS, Oxford Hip Score; Pos, positive; SF-36 PF, Short Form 36 physical function; ST, short-term; THA, total hip arthroplasty; WOMAC, Western Ontario and Mcmaster Universities Osteoarthritis Index.

Of the 15 studies, 7 found a statistically significant association between preoperative physical function and functional outcome.[@R21] [@R28] [@R32] [@R37] [@R38] Nine studies evaluated the short-term functional outcome of which four studies found a significant association.[@R28] [@R30] [@R32] [@R37] Six studies evaluated the long-term functional outcome of which three found a significant association.[@R21] [@R29] [@R38] All studies were designated as level of evidence low (5), moderate (9) or high (1).

In four of the seven studies with a significant outcome, being male predicted a better outcome[@R29] [@R30] [@R32] [@R37] whereas three studies reported being female as a predictor of better functional outcome.[@R21] [@R28] [@R38] This demonstrates inconsistent evidence for an association between gender and functional outcome after THA.

### Preoperative physical function {#s3c4}

Seventeen studies evaluated preoperative physical function as a possible predictor of functional outcome after THA[@R17] [@R23] [@R25] [@R32] [@R34] [@R39] ([table 6](#BMJOPEN2015010725TB6){ref-type="table"}). A total of 9689 patients were included in all studies that evaluated preoperative physical function, with a mean follow-up time of 16 months. The applied levels of measurement of preoperative physical function were continuous, dichotomous or categorical.

###### 

Studies reporting preoperative physical function as possible predictor of functional outcome after THA

                                 Measurement   FU period                    Significance                                        
  ------------------- ---------- ------------- ---------------------------- -------------- -------------- --------------------- ----------------------------------------
  Quintana, 2009      Moderate   788           WOMAC PF                     ST (6 m)       **\<0.001**    Yes                   Cont (WOMAC+SF-36)
                                               SF-36 PF                                                                         
  Slaven, 2012        Low        40            TUG                          ST (6 m)       NA             No                    Dich
                                                                                                                                (successful/unsuccessful)
  Mahomed, 2002       Moderate   103           WOMAC PF+P                   ST (6 m)       **\<0.05**     Yes                   Cont (WOMAC+SF-36)
                                               SF-36 PF                                    **\<0.05**                           
  Hamilton, 2012      Low        1410          OHS                          ST (6 m)       Yes            Yes                   Cont (OHS)
                                               SF-12                        ST (12 m)                                           
  Nankaku, 2013       Moderate   204           Ambulatory status ST (6 m)   **NA**         Yes            Dich (TUG score 10)   
  Vogl, 2014          Low        281           WOMAC                        ST (6 m)       **NA**         Yes                   Cont (WOMAC)
  Bergschmidt, 2010   Moderate   100           WOMAC                        ST (12 m)      \<0.022        Yes                   Cat (3)
                                               SF-36                                       0.003                                1: HHS\<48 2: HHS 48--59 3: HHS\>59
  Clement, 2010       High       1312          OHS                          ST (12 m)      **0.001**\*    Yes                   Cont (OHS)
                                               SF-12                                                                            
  Johansson, 2010     Moderate   75            HHS                          ST (12 m)      **?0.006**     Yes                   Cat (3)
                                               WOMAC                                       **\<0.001**    Yes                   1: HHS\<45 2: HHS 45--55 3: HHS\>55
                                               SF-36                                       **?0.005**     Yes                   
  Nilsdotter, 2002    Moderate   148           WOMAC                        ST (12 m)      **\<0.0001**   Yes                   Dich
                                               SF-36                                                                            Low quartile vs high quartile WOMAC
  Dowsey, 2014        High       835           HHS                          ST (12 m)      **\<0.0001**   Yes                   Cont (HHS)
                                                                                                                                
  Wang, 2010          Moderate   97            WOMAC                        ST (16.8 m)    **0.0001**     Yes                   Cont (WOMAC PF)
  Moran, 2005         Moderate   749           HHS                          ST (18 m)      **NA**         Yes                   Cont
  Fortin, 2002        Low        222           WOMAC                        ST (24 m)      **NA**         Yes                   Dig (1: high WOMAC 2: low WOMAC)
                                               SF-36                                       **NA**         Yes                   
  Smith, 2012         Moderate   1683          HHS                          LT (36 m)      **\<0.001**    Yes                   Cont (HHS)
  Nilsdotter, 2003    Low        211           WOMAC PF                     LT (42 m)      **0.007**      Yes                   Dich
                                                                                                                                Low quartile vs high quartile SF-36 PF
  Judge, 2013         High       1431          OHS                          LT (60 m)      **\<0.001**    Yes                   Cont (OHS)

All significant results are bold.

BMI, body mass index; Cat, categorical; Cont, continuous; Dich, dichotomous; FU, follow-up; HHS, Harris Hip Score; LT, long-term; N of pts, number of patients; NA, not applicable; Neg, negative; OHS, Oxford Hip Score; Pos, positive; SF-36 PF, Short Form 36 physical function; ST, short-term; THA, total hip arthroplasty; WOMAC, Western Ontario and Mcmaster Universities Osteoarthritis Index.

The WOMAC score[@R14] was the measurement tool most used to determine the preoperative physical function.[@R17] [@R27] [@R32] [@R36] [@R37] [@R39] [@R43] Other measurement tools used were the HHS, TUG, OHS, SF-36, SF-12 and the ambulatory status.

Of the 17 studies, 16 found a statistically significant correlation between preoperative physical function and the functional outcome. Fourteen studies evaluated the short-term outcome of which 13 reported a significant association. Three studies evaluated the long-term outcome; all three found a significant association. The only study that did not report a significant association, was a study on a small patient group that used the TUG to determine the preoperative physical function.[@R28] Studies were designated as level of evidence low (5), moderate (9) or high (3).

As more than 60% of the studies report a significant negative association, there is strong evidence of a short-term and long-term association between the preoperative physical function and the functional outcome after THA.

### Comorbidity {#s3c5}

Thirteen studies evaluated comorbidity as a possible predictor of functional outcome after THA ([table 7](#BMJOPEN2015010725TB7){ref-type="table"}). A total of 9363 patients were included in all studies that evaluated comorbidity as a possible predictor, with a mean follow-up time of 23.3 months. The applied levels of measurement of preoperative status were continuous, dichotomous or categorical.

###### 

Studies reporting comorbidity status as possible predictor of functional outcome after THA

                     Measurement   FU period   Significance                                     
  ------------------ ------------- ----------- -------------- ------------- ------------- ----- ---------------------------------------------------------------
  Quintana, 2009     Moderate      788         WOMAC PF       ST (6 m)      NA            No    Cat (3)
                                               SF-36 PF                     NA                  1: 0 comorbidities 2: 1--2 comorbidities 3: \>2 comorbidities
  Mahomed, 2002      Moderate      103         WOMAC PF+P     ST (6 m)      **\<0.05**    Neg   Cont
                                                                                                (number of comorbidities)
  Moran, 2005        Moderate      749         HHS            ST (6 m)      **NA**        Neg   Dich
                                                              ST (18 m)                         (presence of coronary heart disease and
                                                                                                previous thromoembolism)
  Stevens, 2012      Moderate      653         WOMAC          ST (12 m)     **0.01**      Neg   Cat (3)
                                                                                                1: 0 comorbidities 2: 1--2 comorbidities 3: \>2 comorbidities
  Clement, 2010      High          1312        OHS            ST (12 m)     **0.01**      Neg   Cont
                                               SF-12                                            (number of comorbidities)
  Dowsey, 2014       High          835         HHS            ST (12 m)     **0.0001**    Neg   Cont
                                                                                                (age-adjusted CCI)
  Wang, 2010         Moderate      97          WOMAC          ST (16.8 m)   **0.0246**    Neg   Dich
                                                                                                (1: \>0 comorbidities 2: 0 comorbidities)
  Jones, 2012        Moderate      231         WOMAC          LT (36 m)     **0.012**     Neg   Dich
                                                                                                (1; 0 cardiac diseases
                                                                                                2: \>0 cardiac diseases)
  Bischoff, 2004     Moderate      922         WOMAC PF       LT (36 m)     **NA**        Neg   Dich
                                                                                                (1; \>2 chronic diseases
                                                                                                2\. 0--1 chronic diseases)
  Smith, 2012        Moderate      1683        HHS            LT (36 m)     **\<0.001**   Neg   Cont
                                                                                                (ASA grade)
  Gandhi, 2010       Low           636         WOMAC          LT (39 m)     **\<0.05**    Neg   Cont
                                               SF-36 PF                                         (number of comorbidities)
  Nilsdotter, 2003   Low           211         WOMAC PF       LT (42 m)     0.08          No    Dich
                                                                                                (1: \>1 comorbidities 2: 0--1 comorbidities)
  Judge, 2013        High          1431        OHS            LT (60 m)     **0.001**     Neg   Cont
                                                                                                (number of comorbidities)

All significant results are bold.

BMI, body mass index; Cat, categorical; CCI, Charlson comorbidity index; Cont, continuous; Dich, dichotomous; FU, follow-up; HHS, Harris Hip Score; LEFS, Lower Extremity Functional Scale; LT, long-term; N of pts, number of patients; NA, not applicable; Neg, negative; OHS, Oxford Hip Score; Pos, positive; SF-36 PF, Short Form 36 physical function; ST, short-term; THA, total hip arthroplasty; WOMAC, Western Ontario and Mcmaster Universities Osteoarthritis Index.

The measurement tools used to determine the functional outcome were the WOMAC score, HHS, LEFS, SF-36 and the ambulatory status. Most studies used the number of comorbidities or American Society of Anesthestiologists (ASA) grade as predictor of functional outcome. Other studies used the presence of a specific comorbidity as a predictor like cardiac disease, coronary heart disease and thromboembolism.

Of the 13 studies, 11 found a significant negative association.[@R18] [@R21] [@R22] [@R25] [@R27] [@R29] [@R30] [@R32] [@R37] [@R39] [@R42] Seven studies evaluated the short-term outcome of which six reported a significant negative association.[@R22] [@R23] [@R25] [@R30] [@R32] [@R34] [@R39] [@R42] Six studies evaluated the long-term outcome, of which five found a significant negative association.[@R18] [@R21] [@R29] All articles were designated as level of evidence low (2), moderate (8) or high (3).

Since more than 60% of the studies report a significant negative association, there was strong evidence of a negative association between comorbidities and short-term and long-term functional outcomes after THA.

### Other predictors {#s3c6}

The predictors that were evaluated in five studies or less are displayed in [table 8](#BMJOPEN2015010725TB8){ref-type="table"}.

###### 

All predictors that are evaluated in five studies or less

  Predictor       Author, year     Grade      N of pts   Measurement tool    FU-period (months)   Significance level (p value)   Association   Predictor level of measurement
  --------------- ---------------- ---------- ---------- ------------------- -------------------- ------------------------------ ------------- --------------------------------------------
                  Badura-Brzoza,                                                                                                               
  Mental health   2009             Moderate   102        SF-36 PCS           ST (6 m)             **0.005**                      Neg           Cont
                                                                                                                                               (anxiety as a trait)
                  Quintana, 2009   Moderate   788        SF-36 PF            ST (6 m)             **\<0.001**                    Yes           Cont
                                                         WOMAC P             ST (24 m)            **0.002**                                    (SF-36 MH score)
                  Dowsey, 2014     High       835        HSS                 ST (12 m)            **\<0.0001**                   Yes           Cont
                                                                                                                                               (SF-12 MH score)
                  Bischoff, 2004   Moderate   922        WOMAC PF            LT (36 m)            **NA**                         Yes           Dich
                                                                                                                                               (1: \>60 pts on the SF-36 MH score
                                                                                                                                               2: ?60 pts on SF-36 MH score)
                  Judge, 2013      High       916        OHS                 ST (12 m)            **0.045**                      Yes           Cont
                                                                             LT (60 m)                                                         (SF-36 MH score)
  Alcohol         Bischoff, 2004   Moderate   914        WOMAC PF            LT (36 m)            **NA**                         No            Dich
  consumption                                                                                                                                  (1: \>1 alcoholic drinks per day
                                                                                                                                               2: 0--1 alcoholic drinks per day)
                  Lavernia, 2014   Low        191        WOMAC               LT (72 m)            **NA**                         No            Cat (3)
                                                                                                                                               (1: non-drinkers 2: occasional drinkers
                                                                                                                                               3: moderate drinkers)
  Quadriceps      Holstege, 2011   Moderate   55         WOMAC PF            ST (3 m)             **0.004**                      Pos           Cont
  strength                                                                                                                                     (knee extensor strength)
                  Nankaku, 2013    Moderate   204        Ambulatory status   ST (6 m)             **NA**                         Pos           Dich
                                                                                                                                               (1: \>1.25 N m/kg 2: ?1.25 m/kg
                                                                                                                                               knee extensor strength)
  Education       Schafer, 2010    Low        1007       WOMAC               ST (6 m)             **NA**                         Pos           Dich
                                                                                                                                               (1; \>12 years school 2: \<9 years school)
                  Mahomed, 2002    Moderate   103        WOMAC PF+P          ST (6 m)             **0.007**                      Pos           Cont
                                                                                                                                               (level of education)
                  Bischoff, 2004   Moderate   922        WOMAC PF            LT (36 m)            **NA**                         Pos           Dich
                                                                                                                                               (1: college education 2: less
                                                                                                                                               than college education)
  Socioeco        Dowsey, 2014     High       835        HHS                 LT (12 m)            0.63                           No            Cont
  nomic status                                                                                                                                 (SES score)
  Allergies       Graves, 2014     Moderate   459        WOMAC PF            ST (6.5 m)           **0.04**                       Neg           Dich
                                                         SF-36 PCS                                **0.0002**                                   (\>3 allergies)
  Vitamin D       Lavernia, 2013   Moderate   60         HHS                 ST (11 m)            **0.002**                      Neg           Dich (25-hydroxyvitamin D3)
  insufficiency                                          WOMAC                                    0.478                                        (1; \>30 ng/mL 2: \<30 ng/mL)

All significant results are bold.

BMI, body mass index; Cat, categorical; Cont, continuous; Dich, dichotomous; FU, follow-up; HHS, Harris Hip Score; LEFS, Lower Extremity Functional Scale; LT, long-term; N of pts, number of patients; NA, not applicable; Neg, negative; OHS, Oxford Hip Score; PCS, physical component summary scale; Pos, positive; SF-36 PF, Short Form 36 physical function; ST, short-term; WOMAC, Western Ontario and McMaster Universities Osteoarthritis Index.

Five studies evaluated *mental health* as a possible predictor of functional outcome after THA, with a total of 3563 patients.[@R18] [@R23] [@R34] [@R37] [@R44] All four studies evaluating the short-term functional outcome found a significant positive association.[@R23] [@R34] [@R37] [@R44] Both studies that evaluated the long-term outcome found a significant positive association. Since more than 60% of the studies report a significant positive association, there is strong evidence of an association between good mental health and better short-term physical function outcome after THA. Since only two studies evaluated the long-term outcome, this evidence is weak.

Two studies evaluated *alcohol consumption* as a predictor of functional outcome.[@R18] [@R45] Neither of them found a significant result and therefore none show evidence of an association. The two studies evaluating quadriceps strength as a possible predictor[@R26] [@R46] looked at the short-term functional outcome and both found a significant association. Therefore, the evidence for an association is weak.

All three studies that evaluated educational level as a possible predictor found a significant association.[@R18] [@R39] [@R47] Two studies evaluated the short-term outcome and both found a significant association.[@R39] [@R47] One study evaluated the long-term effect and found a significant association.[@R18] All three studies used the WOMAC score to measure the functional outcome. These results show weak evidence for a short-term association, and incomplete evidence for a long-term association.

One study reported *socioeconomic status* (SES) as a predictor, using the SES score as measurement tool.[@R34] They did not find a significant result and therefore show limited evidence of an association.

The influence of having more than three *allergies* on the short-term functional outcome was reported in one study.[@R48] Patients with allergies had diminished improvements on SF-36 PCS and WOMAC scores 6.5 months after THA. There was limited evidence of an association between having more than three allergies and functional outcome.

Vitamin D insufficiency as a predictor of functional outcome after THA was evaluated in one study.[@R49] A preoperative 25-hydroxyvitamin D3 plasma level of under 30 ng/mL, predicted a worse HHS 11 months postoperative. Since no other studies evaluated vitamin D insufficiency as a possible predictor, this result shows limited evidence of an association.

Discussion {#s4}
==========

In this systematic literature review, we sought to provide a clear overview of a range of patient-related predictors of functional outcome after THA.

Key findings {#s4a}
------------

Our review found strong evidence of an association of BMI, age, comorbidity, preoperative physical function and mental health with functional outcome after THA. Weak evidence was found for the predictors like quadriceps strength and education. Inconsistent evidence was found for the predictors like gender and SES. Limited evidence was found for the predictors like alcohol consumption, vitamin D insufficiency and allergies.

In our review, 13 studies found a significant negative association between BMI and functional outcome after THA. A prior review of Young *et al*[@R6] found the same significant negative association. Although the review of Young *et al* and our current review come to the same conclusion, the clinical impact of this outcome is still questionable. A large study by Judge *et al*[@R33] showed a small significant correlation between high BMI and worse functional outcome, but concluded that the total improvement in function outweighs the small lack of improvement caused by high BMI.

Although our review shows strong evidence of an association between BMI and functional outcome, different classifications of high BMI were used. Owing to these different classifications, it is difficult to define a specific BMI that predicts who will do well after THA. We could not conduct a meta-analysis since different classifications of BMI were used and there was heterogeneity in outcome instruments. Therefore, future research on the impact of BMI should use clearly defined outcomes that are consistent across studies.

In our review, 8 of the 14 studies found an association between higher age and poorer functional outcome; therefore, age is an important factor predicting functional outcome. Some articles used a linear regression analysis for age. When looking at age, it is interesting to see the effect of high age, and also of low age. Therefore, linear regression analysis might not be the best statistical analysis with variables as age or BMI. There is no consensus among studies about what specific age limit is recommended for THA. This current review shows inconclusive evidence of an association between gender and functional outcome because 6 out of 14 studies found a statistically significant result.

Three studies reported being female led to a better functional outcome.[@R21] [@R28] [@R38] The other four significant articles found the opposite result where being male had a positive association with functional outcome after THA.[@R29] [@R30] [@R32] [@R37] The results are contradictory and the differences may be attributable to confounding factors.

Preoperative physical function was found to be a strong predictor of long-term functional outcome. With the exception of one study reporting the TUG test as an outcome, better preoperative physical function was consistently associated with better long-term physical function.[@R28] This might be due to the use of TUG score as measurement tool.[@R28] The WOMAC score was the measurement tool most used to define the preoperative status (nine times).[@R17] [@R27] [@R32] [@R36] [@R37] [@R39] [@R43] Other preoperative measurement tools that were good predictors of functional outcome were the HHS, OHS, SF-12 PF, SF-36 PF and the ambulatory status.

Of the 13 studies that evaluated comorbidity as a possible predictor of functional outcome, 11 found a significant negative association.[@R18] [@R21] [@R25] [@R29] [@R30] [@R32] [@R34] [@R37] [@R39] [@R42] Comorbidity can be measured in several ways, for example, the number of comorbidities, the presence of a specific comorbidity, the Charlson index[@R50] and the Elixhauser comorbidity measure.[@R51] Comorbidities can affect the true functional outcome after THA but can also affect the score on the measurement tool. For example, if a patient is unable to walk to the grocery store after a THA due to a lung disease, his functional outcome score will be lower despite a possible good functioning total hip. Except for one article, all studies found a significant negative effect. Therefore, having comorbidities can be seen as a predictor of negative functional outcome.

All five studies that evaluated mental health as a predictor of functional outcome found a statistically significant positive association. Four of these studies used SF-36 MH[@R52] as the measurement tool to measure mental health.[@R18] [@R23] [@R34] [@R37] These results show strong evidence of a positive association between mental health and short-term functional outcome after THA. The two studies reporting quadriceps strength as a predictor had both small sample sizes which can affect the external validity of the studies.[@R26] [@R46] Therefore, this evidence is weak and more research must be carried out on the effect of quadriceps strength.

Three studies evaluated education as predictor of functional outcome. Mahomed *et al*[@R39] and Bischoff *et al*[@R18] used the level of school education as a predictor, and Schäfer *et al*[@R47] used years of education as a predictor. Since education is in part a surrogate of SES, this might also indicate that low SES is a factor associated with poor functional outcome. Dowsey *et al*[@R34] however did not find a correlation between SES and functional outcome. Future research is needed on various components of SES to specify the impact on functional outcome. As only one study evaluated each of the allergies[@R48] and vitamin D insufficiency[@R49] as possible predictors of functional outcome, no conclusions can be drawn.

Previous systematic reviews {#s4b}
---------------------------

The previous systematic review of Young *et al* concluded that important research remained to be done to examine the magnitude and interaction of patient factors on the outcome of THA.[@R6] The review of Young *et al* used only one database (MEDLINE) and is more than 15 years old. Young *et al* also looked at implant survivorship. In our systematic review, we used multiple databases (Web of Science, CINAHL; EMBASE and PubMed) and reported only patient-related predictors evaluated in the literature.

Strengths and limitations {#s4c}
-------------------------

We included a range of patient-related predictors and did not limit ourselves to the most common predictors. This led to a broad overview of predictors evaluated. The reason we could not apply a meta-analysis is because of the heterogeneity across studies regarding measurement tools, predictors and duration of follow-up. Not all studies used in this review adjusted their outcomes for potential confounders. Therefore, some outcomes may be due to confounding factors. A limitation of our review is that we looked at functional outcome without including pain. Some patients will not see an improvement in their function after THA, but will lose the hip-related pain. For this reason especially people with a high BMI and older age can benefit from THA, without improving the function of the hip. Some predictors such as quadriceps strength, education, SES and alcohol consumption are reported only a few times and therefore conclusions cannot be reached. More research in large data sets is needed to draw definitive conclusions on these predictors.

Implications for practice {#s4d}
-------------------------

Our review provides a clear overview of the current literature on the predictors for physical functioning after THA. Orthopaedic surgeons and general practitioners can use this information to predict the improvement in physical functioning of their patients and it enables them to provide patient-specific advice on THA.

Implications for future research {#s4e}
--------------------------------

In the future, we suggest studies that evaluate possible predictors of functional outcome after THA to use similar measurement tools, outcomes and durations of follow-up. In that way a meta-analysis can be applied and the influence of these factors can be specified.

Conclusion {#s5}
==========

This review shows that several patient-related characteristics can predict the functional outcome after THA. It shows strong evidence of an association between BMI, age, comorbidity, preoperative physical function and mental health with functional outcome after THA. Weak evidence suggested that quadriceps strength and education were predictive of functional outcomes after THA. Inconsistent evidence was found for the predictors like gender and SES. Alcohol consumption, vitamin D insufficiency and allergies showed limited evidence predicting functional outcome after THA. Understanding predictors will help orthopaedic surgeons and general practitioners predict the outcomes in physical functioning after THA; they can use this information to provide patient-specific advice and target care for patients with THA. Further well-conducted cohort studies are necessary to confirm these findings.
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